CLINICAL TRIALS PROFILE FOR FOCALIN XR
✉ Email this page to a colleague
All Clinical Trials for FOCALIN XR
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00361387 ↗ | Use of Focalin for Fatigue in Sarcoidosis | Completed | University of Cincinnati | Phase 4 | 2006-06-01 | Patients diagnosed with chronic sarcoidosis with fatigue for more than 6 months. Sarcoidosis and its treatment can greatly affect your quality of life. Many patients suffer from fatigue (feeling tired), lack of focus and concentration, in ability to organize their daily activities, and memory loss. These commonly reported symptoms often get in the way of everyday life. |
| NCT00393042 ↗ | Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR | Completed | Novartis | Phase 3 | 2006-01-01 | The purpose of this study is to evaluate how children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) respond to treatment with three differing doses of stimulant medications used to treat ADHD, Adderall XR® and Focalin XR®. Another purpose of the study is to evaluate if there are differences in sleep and other side effects, such as changes in mood or loss of appetite, which can occur with stimulant medications. A third purpose is to determine if there are differences in the characteristics of individuals who respond better to either of the medications. This research is being done because the investigators do not know if one of these two commonly used treatments is better tolerated than the other. Children and adolescents with ADHD often have a hard time sitting still, playing quietly, finishing things they start, paying attention, waiting their turn, and not distracting others. These medications improve these symptoms, but sometimes affect sleep, appetite, or mood. It is hypothesized that at effective and frequently prescribed doses, Adderall will be associated with insomnia, more stimulant side effects, and decreased tolerability during an acute trial relative to Focalin. |
| NCT00393042 ↗ | Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR | Completed | Seattle Children's Hospital | Phase 3 | 2006-01-01 | The purpose of this study is to evaluate how children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) respond to treatment with three differing doses of stimulant medications used to treat ADHD, Adderall XR® and Focalin XR®. Another purpose of the study is to evaluate if there are differences in sleep and other side effects, such as changes in mood or loss of appetite, which can occur with stimulant medications. A third purpose is to determine if there are differences in the characteristics of individuals who respond better to either of the medications. This research is being done because the investigators do not know if one of these two commonly used treatments is better tolerated than the other. Children and adolescents with ADHD often have a hard time sitting still, playing quietly, finishing things they start, paying attention, waiting their turn, and not distracting others. These medications improve these symptoms, but sometimes affect sleep, appetite, or mood. It is hypothesized that at effective and frequently prescribed doses, Adderall will be associated with insomnia, more stimulant side effects, and decreased tolerability during an acute trial relative to Focalin. |
| NCT00393042 ↗ | Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR | Completed | University of Illinois at Chicago | Phase 3 | 2006-01-01 | The purpose of this study is to evaluate how children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) respond to treatment with three differing doses of stimulant medications used to treat ADHD, Adderall XR® and Focalin XR®. Another purpose of the study is to evaluate if there are differences in sleep and other side effects, such as changes in mood or loss of appetite, which can occur with stimulant medications. A third purpose is to determine if there are differences in the characteristics of individuals who respond better to either of the medications. This research is being done because the investigators do not know if one of these two commonly used treatments is better tolerated than the other. Children and adolescents with ADHD often have a hard time sitting still, playing quietly, finishing things they start, paying attention, waiting their turn, and not distracting others. These medications improve these symptoms, but sometimes affect sleep, appetite, or mood. It is hypothesized that at effective and frequently prescribed doses, Adderall will be associated with insomnia, more stimulant side effects, and decreased tolerability during an acute trial relative to Focalin. |
| NCT00429273 ↗ | Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2007-01-01 | This study will evaluate the effectiveness of a single drug versus a combination of drugs in treating attention deficit hyperactivity disorder in children. |
| NCT00429273 ↗ | Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder | Completed | University of California, Los Angeles | Phase 4 | 2007-01-01 | This study will evaluate the effectiveness of a single drug versus a combination of drugs in treating attention deficit hyperactivity disorder in children. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FOCALIN XR
Condition Name
Clinical Trial Locations for FOCALIN XR
Trials by Country
Clinical Trial Progress for FOCALIN XR
Clinical Trial Phase
Clinical Trial Sponsors for FOCALIN XR
Sponsor Name
